{
  "abstract": "Efficient engineering of human and murine primary T cells without perturbation of cellular function is crucial for immunotherapy and immunology research. Here, we present a protocol for genome editing of primary T cells with minimal toxicity using peptide-assisted genome editing. We describe key steps required for primary T cell isolation and activation, CRISPR ribonucleoprotein (RNP) assembly and delivery mediated by peptide, and assessment of editing efficiency. This protocol maintains T cell proliferative capacity and functional potency.\n\nFor complete details on the use and execution of this protocol, please refer to Zhang et al.1",
  "abstract_shown": true,
  "affiliations": [
    "School of Basic Medical Sciences, Center for Big Data and Population Health of IHM, Anhui Medical University, Hefei, Anhui 230032, China",
    "Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, Anhui 230601, China",
    "Department of Neurobiology, Harbin Medical University, Heilongjiang Provincial Key Laboratory of Neurobiology, Harbin, Heilongjiang 150081, China"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 3,
  "authors": [
    {
      "affs": [
        0,
        1
      ],
      "name": "Jianong Wang"
    },
    {
      "affs": [
        2,
        1
      ],
      "name": "Yifan He"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Zhen Zhang"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/dtfr8b0stn5pj.bib",
  "cited_by": 0,
  "doi": "10.1016/j.xpro.2026.104933",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13745733/",
  "id": "dtfr8b0stn5pj",
  "issns": [
    "2666-1667"
  ],
  "landing_url": "https://doi.org/10.1016/j.xpro.2026.104933",
  "language": "en",
  "licence": "CC-BY-NC-4.0",
  "licence_label": "CC BY-NC 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Protocol"
    ],
    [
      "openalex",
      "1312|CRISPR and Genetic Engineering"
    ]
  ],
  "openalex": "W7225051142",
  "pdf_url": null,
  "pmcid": "PMC13745733",
  "pmid": "42970436",
  "published": "2026-11-01",
  "publisher": "Elsevier",
  "ris": "https://research.draconitic.com/paper/dtfr8b0stn5pj.ris",
  "sources": [
    {
      "first_seen": "2026-11-11T12:23:16Z",
      "native_id": "PMC13745733",
      "source": "pmc",
      "url": "https://doi.org/10.1016/j.xpro.2026.104933"
    }
  ],
  "subjects": [
    {
      "field": "biochemistry",
      "origin": "openalex:1312|CRISPR and Genetic Engineering",
      "subfield": "molecular-biology"
    }
  ],
  "title": "Protocol for engineering primary human and mouse T cells using peptide-assisted genome editing",
  "title_text": "Protocol for engineering primary human and mouse T cells using peptide-assisted genome editing",
  "type": "peer-reviewed",
  "updated_at": "2026-11-13T12:21:36Z",
  "url": "https://research.draconitic.com/paper/dtfr8b0stn5pj",
  "venue": "STAR Protocols",
  "versions": []
}